CHRNA9 antibody

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Ionotropic receptor with a probable role in the modulation of auditory stimuli. Agonist binding induces a conformation change that leads to the opening of an ion-conducting channel across the plasma membrane(PubMed:11752216, PubMed:25282151). The channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane(PubMed:11752216, PubMed:25282151). In the ear, this may lead to a reduction in basilar membrane motion, altering the activity of auditory nerve fibers and reducing the range of dynamic hearing. This may protect against acoustic trauma. May also regulate keratinocyte adhesion(PubMed:11021840).
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | cholinergic receptor, nicotinic, alpha 9 (CHRNA9) |
Host | Rabbit |
Reactivity | Human, Mouse |
Recommended Dilution | WB: 1:500-1:2000 |
Clonality | polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Observed MW | 50-55 kDa |
Purity | ≥95% as determined by SDS-PAGE |
Purification | Immunogen affinity purified |
Size 1 | 100µg |
Form | liquid |
Tested Applications | ELISA, WB |
Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
UniProt ID | Q9UGM1 |
Gene ID | 55584 |
Alias | Neuronal acetylcholine receptor subunit alpha-9,Nicotinic acetylcholine receptor subunit alpha-9 (NACHR alpha-9),CHRNA9,NACHRA9 |
Background | Antibody anti-CHRNA9 |
Status | RUO |
Note | Mol. Weight 50-55 kDa |
Descripción
Related Products

CHRNA9 antibody
Ionotropic receptor with a probable role in the modulation of auditory stimuli. Agonist binding induces a conformation change that leads to the opening of an ion-conducting channel across the plasma membrane(PubMed:11752216, PubMed:25282151). The channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane(PubMed:11752216, PubMed:25282151). In the ear, this may lead to a reduction in basilar membrane motion, altering the activity of auditory nerve fibers and reducing the range of dynamic hearing. This may protect against acoustic trauma. May also regulate keratinocyte adhesion(PubMed:11021840).
Ver Producto
Recombinant Human CHRNA9
Ver Producto
Cholinergic Receptor, Nicotinic Alpha 9 (CHRNA9) Antibody
Rabbit Polyclonal against the CHRNA9 protein.
Ver Producto